EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered compact TnpB epigenetic editors prevent choroidal neovascularization via Vegfa repression

Xiao Tian, Jing Sun, Yongyuan Huo, Cheng Ge, Wenqi Liu, Kaihang Li, Wen Sun, Guanghai Xiang iD, Yong Tao iD, Haoyi Wang iD

Protein & Cell · 13.11.2026

DOI: 10.1093/procel/pwag077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein & Cell, online erschienen am 13.11.2026. Verfasst von Xiao Tian und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic editing enables programmable and heritable gene regulation without altering DNA sequence, yet existing platforms remain constrained by large size, cumbersome target design, and limited applicability. Here we engineered catalytically inactive ISDge10 and ISAam1 TnpB systems and developed highly compact RNA-guided epigenetic editors compatible with single adeno-associated virus (AAV) delivery for either transcriptional activation or repression. Activators based on these TnpBs (Dge10on and Aam1on) efficiently activated diverse endogenous genes in vitro, and AAV9-delivered Aam1on achieved robust pancreatic and duodenal homeobox 1 (Pdx1) activation in vivo. For gene repression, by screening 248 human Krüppel-associated box (KRAB) domains with verified effector activity, we identified the most potent effector domain for each TnpB system, resulting in the optimization of Dge10off and Aam1off. These epigenetic editors mediated durable transcriptional repression across multiple loci in diverse cell types. In a mouse model, single-AAV delivery of these editors efficiently suppressed vascular endothelial growth factor A (Vegfa) expression with no detectable activation of DNA damage response markers (γH2AX and p53), resulting in marked reductions in choroidal neovascularization area. Our study expands the epigenetic editing toolbox and provides a potentially safe and durable single-administration therapeutic strategy for wet age-related macular degeneration (wAMD).

Autor:innen und Institutionen

  • State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
  • Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, Anhui 230601, China.
  • Department of Ophthalmology, Yongchuan Hospital of Chongqing Medical University, Chongqing 402160, China.

ORCID-Profile: Guanghai Xiang, Yong Tao, Haoyi Wang

Zitieren

APA

Tian, X., Sun, J., Huo, Y., Ge, C., Liu, W., Li, K., Sun, W., Xiang, G., Tao, Y., & Wang, H. (2026). Engineered compact TnpB epigenetic editors prevent choroidal neovascularization via Vegfa repression. Protein & Cell. https://doi.org/10.1093/procel/pwag077

Vancouver

Tian X, Sun J, Huo Y, Ge C, Liu W, Li K, et al. Engineered compact TnpB epigenetic editors prevent choroidal neovascularization via Vegfa repression. Protein & Cell. 2026. doi:10.1093/procel/pwag077

BibTeX
@article{Tian2026,
  author = {Tian, Xiao and Sun, Jing and Huo, Yongyuan and Ge, Cheng and Liu, Wenqi and Li, Kaihang and Sun, Wen and Xiang, Guanghai and Tao, Yong and Wang, Haoyi},
  title = {Engineered compact TnpB epigenetic editors prevent choroidal neovascularization via Vegfa repression},
  journal = {Protein & Cell},
  year = {2026},
  doi = {10.1093/procel/pwag077}
}
Kostenlos starten →